Nash Marc's Form 4 filing
Outset Medical, Inc. (OM) · filed Jan 21, 2026
- Accession no.
- 0001484612-26-000018
- Filed
- Jan 21, 2026
- Trade date
- Jan 20-21, 2026
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions. Open-market sales total $32.4K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Nash MarcCIK 0001983815 | Officer (EVP Operations R&D & Service) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 20, 2026 | Common Stock | SSaleDisposed | −5,375 | $5.12 | −$27,520 | 42,785 | Direct | |
| Jan 21, 2026 | Common Stock | SSaleDisposed | −980 | $4.98 | −$4,880.4 | 41,805 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.